CN101921784A - Genes with functions of delta6 fatty acid desaturase and application thereof - Google Patents
Genes with functions of delta6 fatty acid desaturase and application thereof Download PDFInfo
- Publication number
- CN101921784A CN101921784A CN2010101676333A CN201010167633A CN101921784A CN 101921784 A CN101921784 A CN 101921784A CN 2010101676333 A CN2010101676333 A CN 2010101676333A CN 201010167633 A CN201010167633 A CN 201010167633A CN 101921784 A CN101921784 A CN 101921784A
- Authority
- CN
- China
- Prior art keywords
- expression vector
- leu
- plant
- phe
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 52
- 230000006870 function Effects 0.000 title abstract description 7
- 108010037138 Linoleoyl-CoA Desaturase Proteins 0.000 title abstract 2
- 102100020754 Putative fatty acid desaturase 2-like protein FADS2B Human genes 0.000 title abstract 2
- 241000196324 Embryophyta Species 0.000 claims abstract description 46
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 44
- 230000014509 gene expression Effects 0.000 claims abstract description 31
- 210000003527 eukaryotic cell Anatomy 0.000 claims abstract 3
- 239000013604 expression vector Substances 0.000 claims description 33
- 210000004027 cell Anatomy 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 239000013612 plasmid Substances 0.000 claims description 6
- 229920001184 polypeptide Polymers 0.000 claims description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 4
- 244000061176 Nicotiana tabacum Species 0.000 claims description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 4
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 235000013311 vegetables Nutrition 0.000 claims description 3
- 102000007469 Actins Human genes 0.000 claims description 2
- 108010085238 Actins Proteins 0.000 claims description 2
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 2
- 244000105624 Arachis hypogaea Species 0.000 claims description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 2
- 235000018262 Arachis monticola Nutrition 0.000 claims description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 claims description 2
- 241000195493 Cryptophyta Species 0.000 claims description 2
- 244000020551 Helianthus annuus Species 0.000 claims description 2
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 2
- 240000000528 Ricinus communis Species 0.000 claims description 2
- 235000004443 Ricinus communis Nutrition 0.000 claims description 2
- 244000000231 Sesamum indicum Species 0.000 claims description 2
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 2
- 238000004520 electroporation Methods 0.000 claims description 2
- 230000008676 import Effects 0.000 claims description 2
- 238000000520 microinjection Methods 0.000 claims description 2
- 235000020232 peanut Nutrition 0.000 claims description 2
- 240000003768 Solanum lycopersicum Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract description 31
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract description 31
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 abstract description 29
- 229960004232 linoleic acid Drugs 0.000 abstract description 28
- 239000000758 substrate Substances 0.000 abstract description 23
- 235000001466 Ribes nigrum Nutrition 0.000 abstract description 13
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 abstract description 4
- 241001312569 Ribes nigrum Species 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 4
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 abstract description 4
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 abstract description 2
- 229940098330 gamma linoleic acid Drugs 0.000 abstract 3
- 235000020778 linoleic acid Nutrition 0.000 abstract 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 33
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 31
- 229960002733 gamolenic acid Drugs 0.000 description 28
- 239000000194 fatty acid Substances 0.000 description 26
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 22
- 108020004414 DNA Proteins 0.000 description 20
- 239000002253 acid Substances 0.000 description 19
- 235000014113 dietary fatty acids Nutrition 0.000 description 19
- 229930195729 fatty acid Natural products 0.000 description 19
- 150000004665 fatty acids Chemical class 0.000 description 19
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 16
- 239000000047 product Substances 0.000 description 16
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 15
- 101710088194 Dehydrogenase Proteins 0.000 description 13
- 229960004488 linolenic acid Drugs 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 10
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 10
- 238000001819 mass spectrum Methods 0.000 description 10
- 240000001890 Ribes hudsonianum Species 0.000 description 9
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 9
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 9
- 239000013613 expression plasmid Substances 0.000 description 9
- 239000012634 fragment Substances 0.000 description 9
- 238000012216 screening Methods 0.000 description 9
- 150000002632 lipids Chemical class 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 241000589158 Agrobacterium Species 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 235000007689 Borago officinalis Nutrition 0.000 description 6
- 240000004355 Borago officinalis Species 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 6
- 230000006698 induction Effects 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 101710202365 Napin Proteins 0.000 description 5
- 238000013467 fragmentation Methods 0.000 description 5
- 238000006062 fragmentation reaction Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 241000227653 Lycopersicon Species 0.000 description 4
- 235000011483 Ribes Nutrition 0.000 description 4
- 241000220483 Ribes Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000000614 rib Anatomy 0.000 description 4
- 102220023257 rs387907546 Human genes 0.000 description 4
- 210000005253 yeast cell Anatomy 0.000 description 4
- 240000002791 Brassica napus Species 0.000 description 3
- 108700019146 Transgenes Proteins 0.000 description 3
- 235000021342 arachidonic acid Nutrition 0.000 description 3
- 229940114079 arachidonic acid Drugs 0.000 description 3
- 102220369445 c.668T>C Human genes 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- YQYJSBFKSSDGFO-FWAVGLHBSA-N hygromycin A Chemical compound O[C@H]1[C@H](O)[C@H](C(=O)C)O[C@@H]1Oc1ccc(\C=C(/C)C(=O)N[C@@H]2[C@@H]([C@H]3OCO[C@H]3[C@@H](O)[C@@H]2O)O)cc1O YQYJSBFKSSDGFO-FWAVGLHBSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 101100008162 Candida tropicalis Cytb5 gene Proteins 0.000 description 2
- 108010052832 Cytochromes Proteins 0.000 description 2
- 102000018832 Cytochromes Human genes 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 244000196929 Oenothera glazioviana Species 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000006356 dehydrogenation reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 235000004626 essential fatty acids Nutrition 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 102220004457 rs11567847 Human genes 0.000 description 2
- 102220023258 rs387907548 Human genes 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 239000006200 vaporizer Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 235000011297 Brassica napobrassica Nutrition 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 235000002262 Lycopersicon Nutrition 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 241000219960 Oenothera sp. Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- 241000233639 Pythium Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- HXWJFEZDFPRLBG-UHFFFAOYSA-N Timnodonic acid Natural products CCCC=CC=CCC=CCC=CCC=CCCCC(O)=O HXWJFEZDFPRLBG-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 102220369447 c.1352G>A Human genes 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000004129 fatty acid metabolism Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000005477 standard model Effects 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 125000005480 straight-chain fatty acid group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention utilizes two genes RnD6C and RnD6D which root in DNA of Ribes nigrum L. and have complete reading frames and expresses the genes in a yeast expression system. GC-MS analysis shows that the protein coded by the two genes in the yeast can respectively catalyze applied substrates linoleic acid (LA) and alpha-linoleic acid (ALA) to respectively generate gamma-linoleic acid (GLA) and stearidonic acid (SDA). The genes have the functions of delta6 fatty acid desaturase. The genes can be applied to gene engineering technology to produce GLA and SDA by using a lower eukaryotic cell expression system and a plant expression system.
Description
The application is that application number is dividing an application of 2007101194771 patent application.
Technical field
The present invention relates to plant code gene and application thereof.Particularly, relate to two gene RnD6C and RnD6D with entire reading frame frame, it derives from the two segment DNA sequences of blackcurrant (Ribes nigrum L.) respectively, and two gene orders with entire reading frame frame of cloning based on this.The invention still further relates to this coded by said gene and have Δ
6The polypeptide of fatty acid dehydrogenase function, and contain eukaryotic expression vector and plant expression vector, the host cell such as low of this dna sequence dna and utilize this gene to transform the application of lower eukaryotes and plant production GLA and SDA respectively.
Background technology
(Polyunsaturated fatty acids PUFAs) is meant and contains two or more pairs key and carbon chain length is the straight chain fatty acid of 18~22 carbon atoms polyunsaturated fatty acid, mainly comprises linolic acid (linoleic acid, LA, 18:2 Δ
9,12), gamma-linolenic acid (γ-linolenic acid, GLA, 18:3, Δ
6,9,12), arachidonic acid (Arachidonic Acid, AA, 20:4 Δ
5,8,11,14, timnodonic acid (Eicosapentaenoic Acid, EPA, 20:5 Δ
5,8,11,14,17), docosahexenoic acid (Decosahexaenoic Acid, DHA, 20:5 Δ
4,7,10,11,16,19) etc.Wherein, linolic acid and linolenic acid are acknowledged as essential fatty acid (Essential fatty acids, EFA), further derivation become to have the highly unsaturated fatty acids of difference in functionality, as AA, EPA, DHA etc.
PUFAs has very important physiological function.The first, PUFAs plays a significant role in physiological functions such as cardiovascular motion, brain, retina and neurological tissue development.The second, DHA and EPA have the good anticancer effect, as preventing the generation of (especially postmenopausal women) mammary cancer.The 3rd, polyunsaturated fatty acids such as arachidonic acid, EPA and DHA have been brought into play important effect in immunomodulatory.The 4th, polyunsaturated fatty acid can also have the skin aging of preventing, delay senility, promotes effects such as hair growth.
In the fatty acid metabolism process, Δ
6Fatty acid dehydrogenase (Δ
6-fatty acid desaturase, D6D) the 6th carbon atom dehydrogenation of catalytic substrate linolic acid (LA) and alpha-linolenic acid (ALA) forms gamma-linolenic acid (GLA) [1] and therapic acid (Stearidonic acid, SDA, 18:4 Δ respectively
6,9,12,15).
Gamma-linolenic acid can further form AA, Prostaglandins and Leukotrienes class physiologically active substance by carbochain prolongation and dehydrogenation again, and these products produce material impact in a series of physiological functions such as brain development, vision, anaphylaxis and cardiovascular motion of people.A kind of essential unsaturated fatty acids as human body, gamma-linolenic acid has reducing blood-fat, anti peroxidation of lipid, fat-reducing, inhibition ulcer, strengthens a series of biological functions [1 such as Regular Insulin, antithrombotic cardiovascular disorder, 2], be studied utilization [3] as a kind of new VITAMIN-vitamin F in the world at present.SDA is the metabolic precursor thereof of EPA and DHA, is easy to be converted into EPA and DHA in human body, and utilising efficiency is 4 times of ALA, and effectively alleviation lacks relevant physiological maladies with EPA and DHA.Certainly also can obtain effect same by directly replenishing EPA or DHA.
Yet the existing commercial source of PUFAs mainly is specific spermatophyte, marine fishes and some animal tissues.Except LA, the market requirement of growing PUFAs all can not be satisfied in existing source aspect two of ultimate production and quality.This mainly is based on some following reasons:
(1) plant resources of PUFAs is subjected to season and region restriction, the instability of PUFAs output and quality; And plant resources mostly yields poorly, is not suitable for establishing in large scale.For example: the plant biomass such as root of Redsepal Eveningprimrose, Borrago officinalis and blackcurrant that contain gamma-linolenic acid are 300~600kg/ha only, well below the output [4] of the 3t/ha of conventional oil crops such as rape.
(2) limited natural marine fishing resources are because overfishing causes fishing resources to lack, and fish oil inherent fishy smell and oxidative instability, limited the further utilization of PUFAs;
(3) owing to need inferior oil is refined, increased the production cost of PUFAs greatly.Cause the high market value of pure product PUFAs thus, hindered its many potential purposes.
In view of the supply of PUFAs can not satisfy its demand very soon and be applied to the deficiency of the required pure product PUFAs supply of biologics, therefore be necessary the substitutability source of seeking to commercially produce.
So, as the key enzyme-Δ in GLA and the SDA production
6Fatty acid dehydrogenase is more and more studied and is utilized.Up to now, Δ
6Fatty acid dehydrogenase gene clone's acquisition from animal [5], plant [4], fungi [6] and nematode different biologies such as [7], and in yeast saccharomyces cerevisiae [7,8], tomato [9], tobacco [4,10], rape [6,8] and soybean [11], successfully obtained expression.
In plant, GLA and SDA exist only in a few plants such as root of Redsepal Eveningprimrose (Oenothera sp.), Borrago officinalis (Borago officinalis L.), blackcurrant [12], and the seed oil production of these plants also becomes the primary commercial source of present GLA in the world and SDA.Utilize the produce oil fungi fermentation also can extract and obtain GLA and SDA.But the GLA and the SDA output that obtain by existing these modes of production are all very low, can not satisfy the growing market requirement [13] far away.Therefore, utilize yeast saccharomyces cerevisiae or transgenosis oil plant crop plant to express the external source Δ
6GLA produced by fatty acid dehydrogenase and SDA has important Research Significance and economic worth.In addition, though Borrago officinalis [5] have Δ
6The existing abroad research report of fatty acid dehydrogenase gene, but two genes of the application are the Δs that derive from blackcurrant
6Fatty acid dehydrogenase gene does not at home and abroad appear in the newspapers so far.
Summary of the invention
The invention provides two gene RnD6C, RnD6D, its nucleotide acid sequence is respectively shown in SEQID NO:1 and SEQID NO:2, these two genes derive from the dna fragmentation of blackcurrant (Ribesnigrum L.) respectively, encoded polypeptide is respectively as SEQ ID NO:3, shown in the SEQ ID NO:4.
Another object of the present invention provides eukaryotic expression vector such as the Yeast expression carrier such as low that contains gene RnD6C, RnD6D, and utilizes this expression vector transformed yeast cells.Polypeptide expressed in transformed yeast cells has Δ
6Fatty acid dehydrogenase function, catalysis adds the substrate linolic acid and alpha-linolenic acid generates gamma-linolenic acid (GLA) and therapic acid (SDA) respectively respectively.
Because what this genoid was coded is an albumen, can adopt the yeast saccharomyces cerevisiae expression system to carry out vivoexpression, but because this albumen is membranin, even in the vivoexpression system, express, also more difficult separation and purification.So general the employing investigated expressed albumen the method for the catalytic activity that adds substrate carried out Function Identification.
In the yeast saccharomyces cerevisiae expression system that is adopted, recipient bacterium is uridylic defective type INV ScI, itself do not contain LA (linolic acid), ALA (alpha-linolenic acid), GLA (gamma-linolenic acid) and SDA, therefore, adding under the linoleic condition of substrate, if in Yeast engineering bacteria, detect catalysate GLA or SDA, just can determine that the coded albumen of foreign gene has obtained expression in the yeast saccharomyces cerevisiae expression system, produced katalysis to adding substrate.So yeast saccharomyces cerevisiae is as the most frequently used, the effectively expressing system of Δ 6, the functional evaluation of Δ 12-fatty acid dehydrogenase gene of research external source, and existing many successful researchs reports [4,6,7].The detection of lipid acid mainly adopts GC-MS (gas chromatography-mass spectrography technology) to finish.Its principle is by GC (gas-chromatography) different fatty acid components to be separated, and respectively every kind of component is carried out the mass spectrometry analysis by MS (mass spectrum) detector then, thus the coupling analytical technology of the comparative maturity of the composition of definite each component and content.
Another purpose of the present invention provides a kind of plant expression vector that contains gene RnD6C, RnD6D.Can use any expression vector that can guide foreign gene in plant, to express.These plant expression vectors include but not limited to, the double base agrobacterium vector, and for example pBIN19, pBI121, pB221, pCambia 1300, the plant expression vector of pGreen etc.
Carrier of the present invention also can contain suitable promotor.Can use any strong promoter in the present invention.These promotors include but not limited to cauliflower mosaic virus (CaMV 35S), Ubiqutin, Actin promotor.It can use separately or be used in combination with other plant promoter.
Expression vector of the present invention can be by the use Ti-plasmids, the Ri plasmid, and plant viral vector, directly DNA transforms, microinjection, modes such as electroporation import vegetable cell.
The low eucaryon host that waits that can use method of the present invention to transform is selected from the group of being made up of lower eukaryotes such as yeast, algae.
Can use method plant transformed host of the present invention to comprise plants such as tobacco, rape, Sunflower Receptacle, soybean, tomato, castor-oil plant, sesame and peanut.
The invention still further relates to gene RnD6C, the RnD6D application in producing GLA and SDA.
Description of drawings
Fig. 1 .RnD6C fragment nucleotide sequence, SEQ ID NO:1.
Fig. 2 .RnD6D fragment nucleotide sequence, SEQ ID NO:2.
Fig. 3. gene RnD6C encoded polypeptide sequence, SEQ ID NO:3, wherein line part is respectively Cytb5 functional domain and three His Box functional domains.
Fig. 4. gene RnD6D encoded polypeptide sequence, SEQ ID NO:4, wherein line part is respectively Cytb5 functional domain and three His Box functional domains.
Fig. 5. the Yeast expression carrier figure of gene RnD6C and RnD6D.
Fig. 6. the plant expression vector figure of gene RnD6C and RnD6D.A) with the plant expression vector figure of Totomycin (Hyg) as the RnD6C/D of selection markers; B) the plant expression vector figure of the RnD6C/D of removal selection markers.
Fig. 7. the total fatty acids GC-MS that gene RnD6C and RnD6D express in yeast saccharomyces cerevisiae is expressed analyzes
A) GC-MS of INV ScI yeast strain lipid acid composition;
B) GC-MS of LA (linolic acid), GLA (gamma-linolenic acid) standard model is formed and be added with to INV ScI yeast strain lipid acid;
C) contain unloaded pYES2 expression plasmid zymic total fatty acids GC-MS;
D) contain the total fatty acids GC-MS of unloaded pYES2 expression plasmid yeast after adding the LA substrate for induction;
E) the total fatty acids GC-MS of yeast after adding the LA substrate for induction of expression RnD6C gene, the red arrow indication is the product peak;
F) the total fatty acids GC-MS of yeast after adding the LA substrate for induction of expression RnD6D gene, the red arrow indication is the product peak;
G) contain the total fatty acids GC-MS of unloaded pYES2 expression plasmid yeast after adding the ALA substrate for induction;
H) the total fatty acids GC-MS of yeast after adding the ALA substrate for induction of expression RnD6C gene, the red arrow indication is the product peak;
I) the total fatty acids GC-MS of yeast after adding the ALA substrate for induction of expression RnD6D gene, the red arrow indication is the product peak;
J) started the total fatty acids GC-MS of the transgene rape H165 seed of RnD6D genetic expression by the napin promotor, the red arrow indication is the product peak;
K) the total fatty acids GC-MS of contrast-unconverted rape H165 seed.
Fig. 8. MS collection of illustrative plates during RnD6C, RnD6D genetic expression catalysate GC-MS analyze in the yeast saccharomyces cerevisiae, the MS figure of the yeast expression catalysate GLA of a:RnD6C, RnD6D; B: the MS figure of gamma-linolenic acid standard substance.
Embodiment
Describe the present invention in detail below with reference to embodiment and accompanying drawing.What those having ordinary skill in the art will appreciate that is, following embodiment is illustrational purpose, and it should not be interpreted as limitation of the present invention by any way.Protection scope of the present invention is limited by accompanying Claim.
The acquisition of embodiment one, RnD6C, RnD6D gene
1. the preparation of blackcurrant genomic dna
With blackcurrant (Ribes nigrum L.) the live body plant planted in the Beijing Botanical Garden is material, get its young leaflet tablet (about 100mg), in 7ml Ep pipe, add steel ball (diameter 5mm), place the freezing 20-30min of liquid nitrogen, high-speed breakage on the whirlpool device, repeatable operation 2-3 time, broken fully to material.The CTAB extract of adding 1-2ml preheating (referring to " fine works molecular biology experiment guide " 2001, Science Press, Yan Ziying, Wang Hailin is translated), mixing.65 ℃ of water-bath 30min.Add the equal-volume chloroform, the soft about 5min of extracting.In the centrifugal 10min of 12000rpm room temperature.Get supernatant, add 1/2 volume Virahol mixing, room temperature is placed 10min deposit D NA.With the Tip head DNA that is settled out is chosen, with washed twice in 70% ethanol, room temperature is placed 30min in 70% ethanol.Remove 70% ethanol, dry up in the air.Be dissolved in an amount of sterilization ddH
2O ,-20 ℃ of preservations.
2.RnD6C, the clone of RnD6D dna fragmentation
The design primer is cloned RnD6C, RnD6D respectively from the DNA that extract the front dna fragmentation.Used reaction system is as follows:
PCR reaction system (50 μ l):
Cut glue behind the PCR product electrophoresis (1% sepharose concentration) and reclaim purpose fragment (RnD6C, RnD6D, about 1.3kb), be connected into pGEM-T carrier (available from Promega company), sequence verification.
The primer is as follows respectively:
1) clone's the primer of .RnD6C dna fragmentation
Forward primer
Kpn?I
5′-CGCG
GGTACCATGGCTAATGCAATCAAG-3′(SEQ?ID?NO:5)
Reverse primer Sac I
5′-CGCC
GAGCTCTCAGCCATAGGTGTTGAC-3′(SEQ?ID?NO:6)
2) clone's the primer of .RnD6D dna fragmentation
Forward primer Kpn I
5’-CGCG
GGTACCATGGGTGAAAATGGAAGG-3’(SEQ?ID?NO:7)
Reverse primer Sac I
5’-CGCC
GAGCTCTCAACCATAGGTGTTGAC-3’(SEQ?ID?NO:8)
The structure of embodiment two, RnD6C, RnD6D gene yeast carrier
From the pGEM-T carrier that contains gene RnD6C and RnD6D, utilize Kpn I, Sac I restriction enzyme site, two backs of cutting obtain RnD6C and RnD6D gene, directed cloning is in Yeast expression carrier pYES2 (available from Ivitrogen company), obtain expression plasmid of yeast pYRnD6C and pYRnD6D, transformed into escherichia coli DH-5 α (being preserved by this laboratory) preserves.Its carrier figure sees Fig. 5.
Embodiment three, RnD6C, the expression of RnD6D gene in yeast
1. zymic transforms
With reference to the described method of the pYES2 Kit of Invitrogen company (Cat# V285-20), expression plasmid of yeast pYRnD6C and pYRnD6D with above-mentioned mosaic gene, adopt Lithium Acetate mediated transformation yeast saccharomyces cerevisiae auxotrophic strain INV Sc I (purchasing company) in Invitrogen, with unloaded pYES2 plasmid is contrast, obtains to contain the yeast cell of each expression plasmid.
2. the abduction delivering of transformed yeast cell
Get the yeast list bacterium colony that contains the conversion of goal gene expression plasmid of yeast, be inoculated in 50ml SC-U nutrient solution (with reference to the described prescription of the pYES2 Kit of Invitrogen company) and contain in the SC-U nutrient solution of 2% silk floss sugar 250rpm, 28 ℃, overnight incubation; Add NP-40 (available from BBI company) (final concentration 1%), external source linolic acid and alpha-linolenic acid substrate (available from Sigma company) (final concentration is 0.003%), and yeast expression inductor D-semi-lactosi (available from Amresco company) (final concentration is 2%) 250rpm, cultivate the 48h abduction delivering for 22 ℃.
Embodiment four, RnD6C, RnD6D gene yeast representation are to Δ
6The GC-MS of fatty acid dehydrogenase substrate catalysate analyzes
1. the extraction of lipid acid and esterification.
Yeast thalline after centrifugal collection is got and induced, deionized water wash, 50 ℃ of oven dry.Get 40mg yeast powder (yeast of the acquisition of inducing through 50 ℃ of oven dry promptly in example 3.2) and fully grind, add 5ml 5%KOH-CH
3OH adds HCl and is acidified to its pH value and reaches 2.0 behind 70 ℃ of water-bath 5h.Add 4ml14%BF again
3-CH
3OH (available from Aldtich company) solution, 70 ℃ of water-bath 1.5h.Add 2ml 0.9%NaCl solution, static a moment behind the mixing.Add the 2ml chloroform: normal hexane (V/V1: 4) extracting, draw extract, N
2Dry up.Be dissolved in 100 μ l ethyl acetate at last.
2. end product GC-MS check and analysis experiment.
Used GC-/MS instrument is TurboMass (a PerkinElmer company), pillar: BPX-70,30m * 0.25mm * 0.25vm, 120 ℃ of column temperatures, 230 ℃ of vaporizer temperature.Get sample on the 1 μ l end product, splitting ratio 10: 1.
3.GC-MS interpretation of result.
Comparison diagram 7-1a, 7-1b and 7-1e, show and do not adding under the linolic acid substrate condition, used yeast engineering plant and contain in the unloaded pYES2 expression plasmid of inductive yeast and do not have new product peak to occur illustrates not contain in used yeast engineering strain and the unloaded pYES2 expression plasmid zymic total fatty acids to add substrate linolic acid (LA), alpha-linolenic acid (ALA) and catalysate gamma-linolenic acid (GLA), therapic acid (SDA).
When adding the linolic acid substrate, and when carrying out abduction delivering, contrast (unloaded pYES2) does not also have the appearance of product peak gamma-linolenic acid (GLA) (referring to Fig. 7-1d).And after the yeast expression bacterium of pYRnD6C/D induced, add substrate linolic acid (LA) and can be generated gamma-linolenic acid (GLA) (referring to Fig. 7-1e and 7-1f) by catalysis.
Comparison diagram 7-1d, 7-1e and 7-1f can find when retention time is the 7.25min left and right sides, have a new material to generate.Its appearance time and peak figure and the mass spectrum consistent (referring to Fig. 8 a and figure b) of mass spectrum with standard substance gamma-linolenic acid (available from Sigma company) are defined as gamma-linolenic acid.
When adding the alpha-linolenic acid substrate, and when carrying out abduction delivering, contrast (unloaded pYES2) does not also have the appearance of product peak SDA (referring to Fig. 7-2g).And after the yeast expression bacterium of pYRnD6C/D induced, add the substrate alpha-linolenic acid and can be generated SDA (referring to Fig. 7-2h and 7-2i) by catalysis.
Comparison diagram 7-2g, 7-2h and 7-2i can find when retention time is the 7.75min left and right sides, have a new material to generate.Be defined as SDA according to its appearance time and mass spectrum.
Above result's proof derives from two gene RnD6C, RnD6D successful expression in yeast saccharomyces cerevisiae of blackcurrant, and expressed albumen can distinguish catalytic substrate linolic acid (LA) and alpha-linolenic acid (ALA) generates gamma-linolenic acid and SDA.
The structure of embodiment five, RnD6C, RnD6D gene plant expression vector
1.napin the structure of promotor napin-T intermediate carrier
Extract the total DNA of (juncea) rape, (method is referring to embodiment 1.1).Clone's the primer of napin promoter fragment:
Forward primer: Hind III
5′-CGCG
AAGCTTACTACAATGTCGGAGAGACAAGG-3′(SEQID?NO:9)
Reverse primer: BamH I
5′-CGCG
GGATCCTTGTGTATGTTCTGTAGTGATGAGTTTTG-3′(SEQ?ID?NO:10)
With Pyrobest DNA Polymerase pcr amplification (reaction system is referring to embodiment 1.2), cut glue behind the PCR product electrophoresis (1% sepharose concentration) and reclaim purpose fragment (about 1.8kb), be connected into pGEM-T carrier (available from Promega company), sequence verification.
2.RnD6C, the structure of the RnFD6C/D-T intermediate carrier of RnD6D gene
Gene order according to RnFD6C/D, design contains the upstream and downstream special primer that restriction enzyme site is BamH I and Sac I respectively, with Pyrobest DNA Polymerase amplification purpose fragment RnFD6C and RnFD6D, reclaim purpose fragment directed cloning to the pGEM-T carrier, picking list bacterium colony, cut and sequence verification through PCR, enzyme, obtain the RnFD6C/D-T intermediate carrier.
3.RnD6C, the structure of the plant expression vector of RnD6D gene
1) structure of pC1300-napin
With Hind III and BamH I difference double digestion Napin-T and pCambia 1300, and recovery napin promoter fragment and pCambia 1300 carrier segments, connect transformed into escherichia coli, picking mono-clonal at random, through PCR, enzyme is cut checking and is obtained replacing the pC1300-napin plant expression vector that 35S promoter is the napin promotor.
2) structure of pC1300-nRnD6C/D plant expression vector
With BamH I and Sac I difference double digestion RnD6C/D-T and pC1300-napin, and reclaim RnD6C/D purpose fragment and pC1300-napin carrier segments, connect transformed into escherichia coli, picking mono-clonal at random, through PCR, enzyme is cut the plant expression vector that checking obtains pC1300-n RnD6C/D.Its carrier figure sees Fig. 6 a.
3) structure of the pC1300-nRnD6C/D of removal Totomycin (Hyg) selection markers
After building, with Xho I single endonuclease digestion, reclaim big segment then, after connection transformed, the picking mono-clonal carried out PCR at random, enzyme is cut the pC1300-nRnD6C/D plant expression vector that checking obtains to remove Totomycin (Hyg) selection markers.Its carrier figure sees Fig. 6 b.
Embodiment six, RnD6C, RnD6D gene and the conversion in plant
1. plant expression vector changes Agrobacterium over to
The single colony inoculation of picking Agrobacterium in 5ml YEP liquid nutrient medium, 28 ℃, 200rpm, shaken overnight is cultivated.The bacterium liquid of 2ml incubated overnight is added to contains in the 50ml YEP substratum, 28 ℃, 220rpm, shaking culture is to OD
600Between 0.5-1.0.The centrifugal bacterium liquid of 5000rpm is abandoned supernatant, and precipitation is suspended in 10ml 0.5M NaCl, and 4 ℃, the centrifugal 5min of 5000rpm abandons supernatant, with the 20mM CaCl of 1ml precooling
2Re-suspended cell.Get 0.2ml and add about 0.5-1 μ g plasmid DNA, mixing gently, liquid nitrogen flash freezer 1min, 37 ℃ of heat shock 5min, adding 1ml YEP solution, 28 ℃ of shaking culture 2-4h.The centrifugal bacterium liquid of 5000rpm is abandoned supernatant, and cell is resuspended in the 0.2ml YEP substratum, is uniformly coated on the YEP flat board that contains Kan, cultivates 48h for 28 ℃.Picking list bacterium colony carries out PCR and enzyme is cut checking at random.
2.Floral-dip method transforms rape (H165)
Select the swede type rape plant of initial bloom stage to handle, preceding 1d waters permeable in the field.Remove the top bud of main inflorescence and each branched inflorescence, remove open flower simultaneously, only keep soon open bud and be used for transforming.
The Agrobacterium that contains the target gene plant expression vector with 28 ℃ of incubated overnight of substratum of the fresh YEP+kan of 10ml is got the substratum that 5ml changes the fresh YEP+kan of 100ml over to, incubated overnight 22h again to 10:00 next day.The centrifugal Agrobacterium bacterium of 2500rpm liquid, abandon supernatant after, with 100ml transform Bufer (MS minimum medium+sucrose 5%+Silwet-77, pH5.8) resuspended to OD
600=1.0 back dipping brassica napus inflorescences.1d is continuous at interval in the 10d handles 5 times.Put paper bag after having flooded.Remove paper bag behind the dip treating 24h until the results seed.
Embodiment seven, T1 are for the screening of seed
To the rape T1 that obtains after the dip treating for seed through 75% alcohol surface sterilization 30s, 0.1%HgCl
2Sterilization 10min, be layered on the good in advance screening culture medium, through 7~15d screening and culturing, the green seedling of normal growth is carried out resistance screening (7~15d) the 2nd time, resistant plant after the 2nd screening is carried out resistance screening (7~15d) the 3rd time, the 2nd time, the 3rd time screening culture medium is: Ms+Kan (150mg/L).Change the green seedling after the screening for the third time over to flowerpot, hot-house culture to seed is gathered in the crops.
Directly be seeded in the field for the T1 that handles the back acquisition with the Agrobacterium that contains the pC1300-n RnD6C/D that removes selection markers for Semen Brassicae campestris, extract leaf DNA, by PCR screening positive plant.
Embodiment eight, RnD6C, RnD6D gene plant representation are to Δ
6The GC-MS of fatty acid dehydrogenase substrate catalysate analyzes
1. the extraction of lipid acid and esterification.
Get ripe contrast of 50-100mg or transgene rape seed, fully grind in the liquid nitrogen, add 5ml 5%KOH-CH
3OH adds HCl and is acidified to its pH value and reaches 2.0 behind 70 ℃ of water-bath 5h.Add 4ml 14%BF again
3-CH
3OH (available from Aldrich company) solution, 70 ℃ of water-bath 1.5h.Add 2ml 0.9%NaCl solution, static a moment behind the mixing.Add the 2ml chloroform: normal hexane (V/V 1: 4) extracting, draw extract, N
2Dry up.Be dissolved in 100 μ l ethyl acetate at last.
2. end product GC-MS check and analysis experiment.
Used GC/MS instrument is TurboMass (a PerkinElmer company), pillar: BPX-70,30m * 0.25mm * 0.25vm, 120 ℃ of column temperatures, 230 ℃ of vaporizer temperature.Get sample on the 1 μ l end product, splitting ratio 10: 1.
3.GC-MS interpretation of result.
Comparison diagram 7-2j and 7-2k compare with the Semen Brassicae campestris contrast that transforms, and two new product peaks appear in the transformant rape, compare with standard substance and yeast GC-MS result, can find when retention time is the 7.25min left and right sides, the product peak of GLA occurs; When retention time was the 7.75min left and right sides, the product peak of SDA appearred.Above result's proof derives from gene RnD6D successful expression in Semen Brassicae campestris of blackcurrant, and expressed albumen can distinguish catalytic substrate linolic acid (LA) and alpha-linolenic acid (ALA) generates GLA and SDA.This also just shows, changes RnD6C/D over to rape, can produce GLA and SDA as bio-reactor with transgene rape.
Reference:
1.Gunstone?FD(1992)Gamma?linolenic?acid-occurrence?and?physical?andchemical?properties.Prog?Lipid?Res?31:145-161.
2.Horrobin?DF(1992)Nutritional?and?medical?importance?of?gamma-linolenicacid.Prog?Lipid?Res?31:163-194.
3.Huang?YS?and?Milles?DE(1996)Gamma-Linolenic?Acid:Metabolism?andIts?Roles?in?Nutrition?and?Medicine.AOCS?Press,Champaign,IL.
4.Sayanova?O,Smith?MA,Lapinskas?P,Stobart?AK,Dobson?G,Christie?WW,Shewry?PR?and?Napier?JA(1997)Expression?of?a?borage?desaturase?cDNAcontaining?an?N-terminal?cytochrome?b5?domain?results?in?the?accumulationof?high?levels?ofΔ
6-desaturated?fatty?acids?in?transgenic?tobacco.Proc?NatlAcad?Sci?USA?94:4211-4216.
5.Hyekyung?PC,Manabu?TN?and?Steven?DC(1999)Cloning,Expression,andNutritional?Regulation?of?the?MammalianΔ
6-Desaturase.J?Biol?Chem274(1):471-477.
6.Hong?HP,Datla?N,Reed?DW.,Covello?PS,MacKenzie?SL?and?Qiu?X(2002)High-Level?Production?ofγ-Linolenic?Acid?in?Brassica?juncea?Using?aΔ
6Desaturase?from?Pythium?irregulare.Plant?Physiol?129:354-362.
7.Napier?JA,Hey?SJ,Lacey?DJ?and?Shewry?PR(1998)Identification?of?aCaenorhabditis?elegans?Δ
6-fatty-acid-desaturse?by?heterologousexpression?in?Saccharomyces?cerevisiae.Biochem?J?330:611-614.
8.Qiu?X,Hong?HP,Datla?N,MacKenzie?SL,Tayler?CD?and?Thomas?LT(2002)Expression?of?borageΔ
6-desaturase?in?Saccharomyces?cerevisiaeand?oilseed?crops.Can?J?Bot?80:42-49.
9.Cook?D,Grierson?D,Jones?C,Wallace?A,West?G?and?Tucker?G(2002)Modification?of?fatty?acid?composition?in?tomato(Lycopersicon?esculentum)by?expression?of?a?borageΔ
6-desaturase.Mol?Biotechnol.21(2):123-128.
10.Sayanova?O,Smith?MA,Lapinskas?P,Stobart?AK,Dobson?G,ChristieWW,Shewry?PR?and?Napier?JA(1997)Expression?of?a?borage?desaturasecDNA?containing?an?N-terminal?cytochrome?b5?domain?results?in?the?accumulation?of?high?levels?ofΔ
6-desaturated?fatty?acids?in?transgenictobacco.Proc?Natl?Acad?Sci?USA?94:4211-4216.
11.Sato?S,Xing?AQ,Ye?XG,Schweiger?B,Kinney?A,Graef?G?and?Clemente?T(2004)Production?ofγ-Linolenic?Acid?and?Stearidonic?Acid?in?Seeds?ofMarker-Free?Transgenic?Soybean.Crop?Sci?44:646-652.
12.Ucciani?E(1995)Nouveau?Dictionnaire?des?Huiles?Végétales-Composition?en?Acides?Gras.Lavoisier,Paris?pp?3-596.
13.Gyves?EM,Sparks?CA,Sayanova?O,Lazzeri?P,Napier?JA?and?Jones?HD(2004)Genetic?manipulation?ofγ-linolenic?acid(GLA)synthesis?in?acommercial?variety?of?evening?primrose(Oenothera?sp.)Plant?Biotech2(4):351-357.
Sequence table
<110〉Inst. of Genetics and Development Biology, CAS
<120〉have the gene and the application thereof of Δ 6 fatty acid dehydrogenase functions
<130>1
<160>8
<170>PatentIn?version?3.1
<210>1
<211>1347
<212>DNA
<213>Ribes?nigrum?L.
<400>1
atggctaatg?caatcaagaa?gtacatgaca?gttgaggagc?taaaagtgca?taacaagcca 60
gaggatttgt?ggatctctat?tcagggtaag?gtttacaatg?tcactgattg?gaaaaaggaa 120
cacccaggtg?gggatagctc?tctcctgaat?ctaggtggtc?aagatgtcac?agatgcattc 180
attgcttatc?atccaggtac?tgcttggcaa?tatcttgaca?ggttctttac?tgggtattat 240
ctcaaagatt?tcaatgtctc?agatgtatcc?aaagattata?gaaaacttgc?atctgagttt 300
accaaaatgg?gtctttttgc?aaagaaaggg?catggtgttt?tctactcctt?ttgtcttggg 360
gcattcttgt?ttgctgtttg?tgtttatggt?gttttgtatt?ctcaaagttt?gtttgtgcat 420
ttgtgttgtg?gtgggatttt?ggggttttta?tggatgcaaa?gtggttatgc?tggtcacgat 480
tctgggcatt?atcagacaat?gtctactcct?ttttatacca?atttggctca?aattcttact 540
ggaaattgcc?ttagtggtat?tagtatggct?tggtggaaat?ggacccacaa?tgctcaccac 600
gttgctgtta?atagtattga?ccatgaccct?gatcttcagt?acatgccatt?ttttgtcctc 660
tctcccaaat?tgttcaatgg?cataacttct?cgcttttatg?ggaggaagtt?ggagtttgat 720
gcttttgcta?ggttcatggt?aagttatcag?cattggacat?tttatccggt?gatgattttt 780
gcacgatttt?atatgtttgt?gcccacgttt?tttatgttgc?tttcaaagaa?aaaagtaccc 840
aacagacctt?tgaatatagc?gggaattatt?gtgttctgga?tttggtttcc?tcttcttgtt 900
tcatgccttc?ccaattggac?tgagaggatg?atgtttgtgc?tagtgagctt?tacagttact 960
tcaattcaac?acgttacatt?ttgtttgaat?cactactcgg?ctgataatta?tatgggacat 1020
cctactggga?acgattggtt?tgagaagcag?acaagtggga?ctttggacat?ttcgtgcccg 1080
tcttggatgg?attggtttca?tggtgggctg?caattccaaa?ttgagcatca?tttgttccca 1140
agattgcctc?gatgccagct?taggaaggtc?tctccttttg?tgaaagagct?ttgcaagaaa 1200
cacaatttgc?cttataggag?tttatcattt?tttgaggcca?atgttgcaat?cattaagacg 1260
ttgaggactg?ccgccttgca?agctcgcgac?ctatccaacc?ctatttcaaa?gaatttgcta 1320
tgggaagctg?tcaacaccta?tggctga 1347
<210>2
<211>1347
<212>DNA
<213>Ribes?nigrum?L.
<400>2
atgggtgaaa?atggaaggaa?gtacatgaca?gttgaggagc?taaaagtgca?taataagcca 60
gaggatttgt?ggatctctat?tcagggtaag?gtttacaatg?tcactgattg?gaaaaaggaa 120
cacccaggtg?gggatagctc?actcctgaat?ctgggtggtc?aagatgtcac?agatgcattc 180
attgcttatc?atccaggtac?tgtttggcaa?tatcttgaca?ggttctttac?tgggtattat 240
ctcaaagatt?tcaaagtctc?agatgtatcc?aaagattaca?gaaaacttgc?atctgagttt 300
accaaaatgg?gtctttttgc?aaagaaaggg?catggtgttt?tctactcctt?ttgtcttggg 360
gcattcttgt?ttgctgtttg?tgtttatggt?gttttgtatt?ctcaaagttt?gtttgtgcat 420
ttatgttgtg?gtgggatttt?ggggttttta?tggatgcaaa?gtggttatgc?tggtcatgat 480
tctgggcatt?accagacaat?gtctactcct?ttttatacca?atttggctca?aattcttact 540
ggaaattgcc?ttagtggtat?tagtatggct?tggtggaaat?ggacccacaa?tgctcaccac 600
attgctgtta?atagtattga?ccatgaccct?gatcttcagt?acatgccatt?ttttgttctc 660
tctcccaaat?tgttcaatag?cataacttct?cgcttttatg?ggaggaagtt?ggagtttgat 720
gcttttgcta?ggttcatggt?gagttatcag?cattggacat?tttatccggt?gatgattttt 780
gcacgatttt?atatgtttgt?gcctacgttt?tttttgttgc?tttcaaagaa?aaaagtaccc 840
aacagacttt?tgaatatagc?tggaattatt?gtgttctgga?tttggtttcc?tcttcttgtt 900
tcatgcctac?ccaattggac?tgagaggatg?atgtttgtgc?tagtgagctt?tacggttact 960
tcaattcaac?acgttacatt?ttgtttgaat?cactactcgg?ctgataatta?tatgggacat 1020
cctactggga?acgattggtt?tgaaaagcag?acaagtggga?ctttggacat?ttcgtgcccg 1080
tcttggatgg?attggtttca?tggtgggctg?caattccaac?ttgagcatca?tttgttccct 1140
cgaatgcctc?gatgtcagct?taggaaggtc?tctccttttg?tgaaggaact?ttgccagaag 1200
cataatttgc?cttataggag?tttgtcattt?ttcgaggcca?atgtcgcgac?cattaagacg 1260
ttgaggactg?cagccttgca?agctcgtgac?ctgtccaacc?ctattacaaa?gaatttgcta 1320
tgggaagctg tcaacaccta tggttga 1347
<210>3
<211>448
<212>PRT
<213>Ribes?nigrum?L.
<400>3
Met?Ala?Asn?Ala?Ile?Lys?Lys?Tyr?Met?Thr?Val?Glu?Glu?Leu?Lys?Val
1 5 10 15
His?Asn?Lys?Pro?Glu?Asp?Leu?Trp?Ile?Ser?Ile?Gln?Gly?Lys?Val?Tyr
20 25 30
Asn?Val?Thr?Asp?Trp?Lys?Lys?Glu?His?Pro?Gly?Gly?Asp?Ser?Ser?Leu
35 40 45
Leu?Asn?Leu?Gly?Gly?Gln?Asp?Val?Thr?Asp?Ala?Phe?Ile?Ala?Tyr?His
50 55 60
Pro?Gly?Thr?Ala?Trp?Gln?Tyr?Leu?Asp?Arg?Phe?Phe?Thr?Gly?Tyr?Tyr
65 70 75 80
Leu?Lys?Asp?Phe?Asn?Val?Ser?Asp?Val?Ser?Lys?Asp?Tyr?Arg?Lys?Leu
85 90 95
Ala?Ser?Glu?Phe?Thr?Lys?Met?Gly?Leu?Phe?Ala?Lys?Lys?Gly?His?Gly
100 105 110
Val?Phe?Tyr?Ser?Phe?Cys?Leu?Gly?Ala?Phe?Leu?Phe?Ala?Val?Cys?Val
115 120 125
Tyr?Gly?Val?Leu?Tyr?Ser?Gln?Ser?Leu?Phe?Val?His?Leu?Cys?Cys?Gly
130 135 140
Gly?Ile?Leu?Gly?Phe?Leu?Trp?Met?Gln?Ser?Gly?Tyr?Ala?Gly?His?Asp
145 150 155 160
Ser?Gly?His?Tyr?Gln?Thr?Met?Ser?Thr?Pro?Phe?Tyr?Thr?Asn?Leu?Ala
165 170 175
Gln?Ile?Leu?Thr?Gly?Asn?Cys?Leu?Ser?Gly?Ile?Ser?Met?Ala?Trp?Trp
180 185 190
Lys?Trp?Thr?His?Asn?Ala?His?His?Val?Ala?Val?Asn?Ser?Ile?Asp?His
195 200 205
Asp?Pro?Asp?Leu?Gln?Tyr?Met?Pro?Phe?Phe?Val?Leu?Ser?Pro?Lys?Leu
210 215 220
Phe?Asn?Gly?Ile?Thr?Ser?Arg?Phe?Tyr?Gly?Arg?Lys?Leu?Glu?Phe?Asp
225 230 235 240
Ala?Phe?Ala?Arg?Phe?Met?Val?Ser?Tyr?Gln?His?Trp?Thr?Phe?Tyr?Pro
245 250 255
Val?Met?Ile?Phe?Ala?Arg?Phe?Tyr?Met?Phe?Val?Pro?Thr?Phe?Phe?Met
260 265 270
Leu?Leu?Ser?Lys?Lys?Lys?Val?Pro?Asn?Arg?Pro?Leu?Asn?Ile?Ala?Gly
275 280 285
Ile?Ile?Val?Phe?Trp?Ile?Trp?Phe?Pro?Leu?Leu?Val?Ser?Cys?Leu?Pro
290 295 300
Asn?Trp?Thr?Glu?Arg?Met?Met?Phe?Val?Leu?Val?Ser?Phe?Thr?Val?Thr
305 310 315 320
Ser?Ile?Gln?His?Val?Thr?Phe?Cys?Leu?Asn?His?Tyr?Ser?Ala?Asp?Asn
325 330 335
Tyr?Met?Gly?His?Pro?Thr?Gly?Asn?Asp?Trp?Phe?Glu?Lys?Gln?Thr?Ser
340 345 350
Gly?Thr?Leu?Asp?Ile?Ser?Cys?Pro?Ser?Trp?Met?Asp?Trp?Phe?His?Gly
355 360 365
Gly?Leu?Gln?Phe?Gln?Ile?Glu?His?His?Leu?Phe?Pro?Arg?Leu?Pro?Arg
370 375 380
Cys?Gln?Leu?Arg?Lys?Val?Ser?Pro?Phe?Val?Lys?Glu?Leu?Cys?Lys?Lys
385 390 395 400
His?Asn?Leu?Pro?Tyr?Arg?Ser?Leu?Ser?Phe?Phe?Glu?Ala?Asn?Val?Ala
405 410 415
Ile?Ile?Lys?Thr?Leu?Arg?Thr?Ala?Ala?Leu?Gln?Ala?Arg?Asp?Leu?Ser
420 425 430
Asn?Pro?Ile?Ser?Lys?Asn?Leu?Leu?Trp?Glu?Ala?Val?Asn?Thr?Tyr?Gly
435 440 445
<210>4
<211>448
<212>PRT
<213>Ribes?nigrum?L.
<400>4
Met?Gly?Glu?Asn?Gly?Arg?Lys?Tyr?Met?Thr?Val?Glu?Glu?Leu?Lys?Val
1 5 10 15
His?Asn?Lys?Pro?Glu?Asp?Leu?Trp?Ile?Ser?Ile?Gln?Gly?Lys?Val?Tyr
20 25 30
Asn?Val?Thr?Asp?Trp?Lys?Lys?Glu?His?Pro?Gly?Gly?Asp?Ser?Ser?Leu
35 40 45
Leu?Asn?Leu?Gly?Gly?Gln?Asp?Val?Thr?Asp?Ala?Phe?Ile?Ala?Tyr?His
50 55 60
Pro?Gly?Thr?Val?Trp?Gln?Tyr?Leu?Asp?Arg?Phe?Phe?Thr?Gly?Tyr?Tyr
65 70 75 80
Leu?Lys?Asp?Phe?Lys?Val?Ser?Asp?Val?Ser?Lys?Asp?Tyr?Arg?Lys?Leu
85 90 95
Ala?Ser?Glu?Phe?Thr?Lys?Met?Gly?Leu?Phe?Ala?Lys?Lys?Gly?His?Gly
100 105 110
Val?Phe?Tyr?Ser?Phe?Cys?Leu?Gly?Ala?Phe?Leu?Phe?Ala?Val?Cys?Val
115 120 125
Tyr?Gly?Val?Leu?Tyr?Ser?Gln?Ser?Leu?Phe?Val?His?Leu?Cys?Cys?Gly
130 135 140
Gly?Ile?Leu?Gly?Phe?Leu?Trp?Met?Gln?Ser?Gly?Tyr?Ala?Gly?His?Asp
145 150 155 160
Ser?Gly?His?Tyr?Gln?Thr?Met?Ser?Thr?Pro?Phe?Tyr?Thr?Asn?Leu?Ala
165 170 175
Gln?Ile?Leu?Thr?Gly?Asn?Cys?Leu?Ser?Gly?Ile?Ser?Met?Ala?Trp?Trp
180 185 190
Lys?Trp?Thr?His?Asn?Ala?His?His?Ile?Ala?Val?Asn?Ser?Ile?Asp?His
195 200 205
Asp?Pro?Asp?Leu?Gln?Tyr?Met?Pro?Phe?Phe?Val?Leu?Ser?Pro?Lys?Leu
210 215 220
Phe?Asn?Ser?Ile?Thr?Ser?Arg?Phe?Tyr?Gly?Arg?Lys?Leu?Glu?Phe?Asp
225 230 235 240
Ala?Phe?Ala?Arg?Phe?Met?Val?Ser?Tyr?Gln?His?Trp?Thr?Phe?Tyr?Pro
245 250 255
Val?Met?Ile?Phe?Ala?Arg?Phe?Tyr?Met?Phe?Val?Pro?Thr?Phe?Phe?Leu
260 265 270
Leu?Leu?Ser?Lys?Lys?Lys?Val?Pro?Asn?Arg?Leu?Leu?Asn?Ile?Ala?Gly
275 280 285
Ile?Ile?Val?Phe?Trp?Ile?Trp?Phe?Pro?Leu?Leu?Val?Ser?Cys?Leu?Pro
290 295 300
Asn?Trp?Thr?Glu?Arg?Met?Met?Phe?Val?Leu?Val?Ser?Phe?Thr?Val?Thr
305 310 315 320
Ser?Ile?Gln?His?Val?Thr?Phe?Cys?Leu?Asn?His?Tyr?Ser?Ala?Asp?Asn
325 330 335
Tyr?Met?Gly?His?Pro?Thr?Gly?Asn?Asp?Trp?Phe?Glu?Lys?Gln?Thr?Ser
340 345 350
Gly?Thr?Leu?Asp?Ile?Ser?Cys?Pro?Ser?Trp?Met?Asp?Trp?Phe?His?Gly
355 360 365
Gly?Leu?Gln?Phe?Gln?Leu?Glu?His?His?Leu?Phe?Pro?Arg?Met?Pro?Arg
370 375 380
Cys?Gln?Leu?Arg?Lys?Val?Ser?Pro?Phe?Val?Lys?Glu?Leu?Cys?Gln?Lys
385 390 395 400
Sequence table
His?Asn?Lcu?Pro?Tyr?Arg?Ser?Leu?Ser?Phe?Phe?Glu?Ala?Asn?Val?Ala
405 410 415
Thr?Ile?Lys?Thr?Leu?Arg?Thr?Ala?Ala?Leu?Gln?Ala?Arg?Asp?Leu?Ser
420 425 430
Asn?Pro?Ile?Thr?Lys?Asn?Leu?Leu?Trp?Glu?Ala?Val?Asn?Thr?Tyr?Gly
435 440 445
<210>5
<211>28
<212>DNA
<213〉artificial sequence
<400>5
cgcgggtacc?atggctaatg?caatcaag 28
<210>6
<211>28
<212>DNA
<213〉artificial sequence
<400>6
cgccgagct?c?tcagccatag?gtgttgac 28
<210>7
<211>28
<212>DNA
<213〉artificial sequence
<400>7
cgcgggtacc?atgggtgaaa?atggaagg 28
<210>8
<211>28
<212>DNA
<213〉artificial sequence
<400>8
cgccgagctc?tcaaccatag?gtgttgac 28
<210>9
<211>33
<212>DNA
<213〉artificial sequence
<400>9
cgcgaagctt?actacaatgt?cggagagaca?agg 33
<210>10
<211>39
<212>DNA
<213〉artificial sequence
<400>10
cgcgggatcc?ttgtgtatgt?tctgtagtga?tgagtttg 39
Claims (12)
1. gene RnD6C, its nucleotide sequence is shown in SEQ ID NO:1.
2. the gene RnD6C encoded polypeptide of claim 1, its aminoacid sequence is shown in SEQ ID NO:3.
3. an expression vector is characterized in that comprising the described gene of claim 1.
4. the expression vector of claim 3, it is low eukaryotic expression vector or the plant expression vector of waiting.
5. the expression vector of claim 4, wherein low to wait eukaryotic expression vector be pYES2.
6. the expression vector of claim 4, wherein said plant expression vector is the plant expression vector that is selected from pBIN19, pBI121, pB221, pCambia 1300 and pGreen.
7. the expression vector of claim 3, it is characterized in that also comprising promotor, described promotor is selected from cauliflower mosaic virus CaMV35S, Ubiqutin, Actin or plant tissue position specific expression promoter, and described promotor is used in combination separately or with other plant promoter.
8. host cell is characterized in that comprising the expression vector of claim 3.
9. the host cell of claim 8, wherein said expression vector are that the mode by Ti-plasmids, Ri plasmid, plant virus-based expression vector, directly DNA conversion, microinjection or electroporation imports.
10. the host cell of claim 8, it is low eukaryotic cell or the vegetable cell of waiting.
11. the host cell of claim 10, wherein said low eukaryotic cell such as grade is the cell of yeast, algae, and described vegetable cell comprises the cell of tobacco, rape, Sunflower Receptacle, soybean, tomato, castor-oil plant, sesame and peanut.
12. the application of the gene RnD6C of claim 1 in producing GLA and SDA.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101676333A CN101921784B (en) | 2007-07-25 | 2007-07-25 | Genes with functions of delta6 fatty acid desaturase and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101676333A CN101921784B (en) | 2007-07-25 | 2007-07-25 | Genes with functions of delta6 fatty acid desaturase and application thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101194771A Division CN101353661B (en) | 2007-07-25 | 2007-07-25 | Genes having delta 6 fatty acid dehydrogenase function and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101921784A true CN101921784A (en) | 2010-12-22 |
CN101921784B CN101921784B (en) | 2012-05-30 |
Family
ID=43336999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101676333A Expired - Fee Related CN101921784B (en) | 2007-07-25 | 2007-07-25 | Genes with functions of delta6 fatty acid desaturase and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101921784B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102965351A (en) * | 2012-11-09 | 2013-03-13 | 浙江工业大学 | Cordyceps sinensis omega-6 fatty acid-dehydrogenase, gene and application of gene |
-
2007
- 2007-07-25 CN CN2010101676333A patent/CN101921784B/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102965351A (en) * | 2012-11-09 | 2013-03-13 | 浙江工业大学 | Cordyceps sinensis omega-6 fatty acid-dehydrogenase, gene and application of gene |
Also Published As
Publication number | Publication date |
---|---|
CN101921784B (en) | 2012-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104024403B (en) | Production of dha and other lc-pufas in plants | |
US10174297B2 (en) | Fatty acid desaturases from primula | |
CN100567483C (en) | Fatty acid desaturase family member FAD4, FAD5, FAD5-2 and FAD6 and their application | |
ES2656217T3 (en) | Production of DHA and other LC-PUFA in plants | |
JP2006509494A (en) | Fatty acid desaturase from fungi | |
CN105755017A (en) | Lowering Saturated Fatty Acid Content Of Plant Seeds | |
CN101353661B (en) | Genes having delta 6 fatty acid dehydrogenase function and use thereof | |
CN106413389A (en) | Production of omega-3 long-chain polyunsaturated fatty acids in oilseed crops by a thraustochytrid PUFA synthase | |
CN109402079B (en) | Application of polypeptide in improving content of plant ultra-long chain fatty acid | |
CN101921784B (en) | Genes with functions of delta6 fatty acid desaturase and application thereof | |
CN100413969C (en) | Chimeric gene with delta 6 fatty acid dehydrogenase function and its use | |
CN109837290B (en) | Application of ShFAD2 gene family and ShFAD3 gene family in creating transgenic plants with high ALA yield | |
CN102399758B (en) | Mutant gene mRnD6D having delta <6> fatty acid dehydrogenase functions and use thereof | |
TW200520679A (en) | Arachidonic acid-containing plants and use of the plants | |
KR102184816B1 (en) | Metabolic engineering of the DHA biosynthetic pathway into transgenic perilla | |
CN109477079A (en) | Increase the method for omega-3 polyunsaturated fatty acids yield in microalgae | |
CN101724638A (en) | Nucleotide sequence of euglenagracilis coded delta 8 dehydrogenase and application thereof | |
KR101424116B1 (en) | Transgenic perrilla plant transformed with delta-6 desaturase gene from phytophthora citrophthora and the method for producing the same | |
CN101724637B (en) | Nucleotide sequence of delta 9 extending enzyme of chromulina, such as ball and the like, and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120530 Termination date: 20170725 |